Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating firsocostat or fenofibrate in adults with normal and impaired hepatic function; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Firsocostat (firsocostat)

Snippet

Sponsor: Gilead Sciences | Conditions: Nonalcoholic Steatohepatitis (NASH) | Phase 1 | Status: COMPLETED | Results posted: 2020-12-17